# Clonal Hematopoiesis Chemotherapy and Radiation Effects Study

> **NCT07675967** · — · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 5000 (estimated)

## Conditions studied

- Lung Cancer (Diagnosis)
- Osteochondroma
- Spitz Nevus
- Solid Cancers
- Breast Cancer
- Gastric (Stomach) Cancer
- Colorectal (Colon or Rectal) Cancer
- Sarcoma
- Ovarian Adenocarcinoma
- Uterine Adenocarcinoma
- Endometrial Adenocarcinoma
- Esophageal Adenocarcinoma
- Head and Neck Cancer
- Therapy-Related Acute Myeloid Leukemia
- Therapy-Related MDS
- Clonal Hematopoiesis of Indeterminate Potential (CHIP)
- Clonal Cytopenia of Undetermined Significance

## Interventions

- **OTHER:** Samples

## Key facts

- **NCT ID:** NCT07675967
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-04
- **Primary completion:** 2028-06-30
- **Final completion:** 2035-03-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675967, "Clonal Hematopoiesis Chemotherapy and Radiation Effects Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*